Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-20-009777

Corporate Executive VP & CCO sold 13,966 shares at an average $164.35 ($2,295,300)

  • Corporate Executive VP & CCO acquired 12,467 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise +3,015 $73.70 $222,206 20,749 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise +3,492 $88.05 $307,471 24,241 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise +3,205 $109.34 $350,435 27,446 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise +2,755 $144.67 $398,566 30,201 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Sale −8,961 $164.09 $1,470,448 21,240 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Sale −5,005 $164.81 $824,852 16,235 D
Derivatives
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise · Stock Options (Right to Buy) −3,015 0 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise · Stock Options (Right to Buy) −3,492 3,493 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise · Stock Options (Right to Buy) −3,205 6,409 D
Barbo William D Corporate Executive VP & CCO 2020-03-05 Option exercise · Stock Options (Right to Buy) −2,755 8,266 D
Open-market sales · 13,966 sh · avg $164.35 · $2,295,300
Loading xslF345X03/form4.xml…